Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Herpes viruses hedge their bets: latency boosts survival

31.10.2002


Herpes viruses have two infectious phases: one just after infecting a new host, and one years or decades later when they reactivate.



According Michael Stumpf (UCL), Zoe Laidlaw (University of Sheffield), and Vincent Jansen (Royal Holloway, University of London), that latency period evolved because it allows the viruses to flourish when the availability of hosts from year to year is highly unpredictable.

Until now, scientists have thought that viruses like herpes simplex 1 and 2, Epstein-Barr virus, and varicella zoster virus, which causes chickenpox and shingles, had evolved latency periods in order to allow them to survive in small host populations.


The new research offers an alternative explanation: the viruses are hedging their bets against the possibility that a sudden outbreak immunises a large part of the population thus drastically reducing the pool of potential hosts. Even in large populations this makes the world very unpredictable from the point view of the virus. The researchers used a mathematical model of how the virus spreads through host populations to determine whether viruses with latency periods could out-compete viruses without latency periods. They found that viruses with latency periods had an evolutionary advantage when the availability of hosts was unpredictable: generally the more unpredictable the environment the more important latency became.

Such dynamics are not limited to viruses: there are many situations, for example portfolio and fund management where a balance between action and patience has to be struck. The present piece of research suggests that successful strategies may often be embarassingly simple: be patient and save something to see you through leaner years.

Katie Price | alfa
Further information:
http://www.pnas.org/cgi/content/abstract/232546899v1

More articles from Health and Medicine:

nachricht Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg

nachricht Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Small Protein, Big Impact

In meningococci, the RNA-binding protein ProQ plays a major role. Together with RNA molecules, it regulates processes that are important for pathogenic properties of the bacteria.

Meningococci are bacteria that can cause life-threatening meningitis and sepsis. These pathogens use a small protein with a large impact: The RNA-binding...

Im Focus: K-State study reveals asymmetry in spin directions of galaxies

Research also suggests the early universe could have been spinning

An analysis of more than 200,000 spiral galaxies has revealed unexpected links between spin directions of galaxies, and the structure formed by these links...

Im Focus: New measurement exacerbates old problem

Two prominent X-ray emission lines of highly charged iron have puzzled astrophysicists for decades: their measured and calculated brightness ratios always disagree. This hinders good determinations of plasma temperatures and densities. New, careful high-precision measurements, together with top-level calculations now exclude all hitherto proposed explanations for this discrepancy, and thus deepen the problem.

Hot astrophysical plasmas fill the intergalactic space, and brightly shine in stellar coronae, active galactic nuclei, and supernova remnants. They contain...

Im Focus: Biotechnology: Triggered by light, a novel way to switch on an enzyme

In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".

Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...

Im Focus: New double-contrast technique picks up small tumors on MRI

Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.

researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Dresden Nexus Conference 2020: Same Time, Virtual Format, Registration Opened

19.05.2020 | Event News

Aachen Machine Tool Colloquium AWK'21 will take place on June 10 and 11, 2021

07.04.2020 | Event News

International Coral Reef Symposium in Bremen Postponed by a Year

06.04.2020 | Event News

 
Latest News

Why developing nerve cells can take a wrong turn

04.06.2020 | Life Sciences

The broken mirror: Can parity violation in molecules finally be measured?

04.06.2020 | Physics and Astronomy

Innocent and highly oxidizing

04.06.2020 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>